These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27938345)

  • 41. Time from blood draw to multiple electrode aggregometry and association with platelet reactivity.
    Hesselbarth D; Gjermeni D; Szabo S; Siegel PM; Diehl P; Moser M; Bode C; Olivier CB
    J Thromb Thrombolysis; 2023 Jan; 55(1):134-140. PubMed ID: 36344849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet function testing in transient ischaemic attack and ischaemic stroke: A comprehensive systematic review of the literature.
    Lim ST; Coughlan CA; Murphy SJ; Fernandez-Cadenas I; Montaner J; Thijs V; Marquardt L; McCabe DJ
    Platelets; 2015; 26(5):402-12. PubMed ID: 26042726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Drugs Ther; 2015; 29(5):443-50. PubMed ID: 26428927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study.
    Jastrzębska M; Chełstowski K; Wódecka A; Siennicka A; Clark J; Nowacki P
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):830-8. PubMed ID: 24071649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Description of response to aspirin and clopidogrel in outpatients with coronary artery disease using multiple electrode impedance aggregometry.
    Gerotziafas GT; Zarifis J; Bandi A; Mossialos L; Galea V; Tsinopoulos G; Chaari M; Baccouche H; Sassi M; Elalamy I
    Clin Appl Thromb Hemost; 2012 Jul; 18(4):356-63. PubMed ID: 22311629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.
    Gajos G; Rostoff P; Undas A; Piwowarska W
    J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
    Grau AJ; Reiners S; Lichy C; Buggle F; Ruf A
    Stroke; 2003 Apr; 34(4):849-54. PubMed ID: 12637702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of increasing doses of aspirin on platelet aggregation among stroke patients.
    Gan R; Teleg RA; Florento L; Bitanga ES
    Cerebrovasc Dis; 2002; 14(3-4):252-5. PubMed ID: 12403959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment.
    Becatti M; Fiorillo C; Gori AM; Marcucci R; Paniccia R; Giusti B; Violi F; Pignatelli P; Gensini GF; Abbate R
    Atherosclerosis; 2013 Dec; 231(2):392-400. PubMed ID: 24267257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual antiplatelet therapy tailored on platelet function test after coronary stent implantation: a real-world experience.
    Cecchi E; Marcucci R; Chiostri M; Mecarocci V; Spini V; Innocenti L; Calabretta R; Cordisco A; Romano SM; Abbate R; Gensini GF; Giglioli C
    Intern Emerg Med; 2015 Oct; 10(7):805-14. PubMed ID: 25944129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin.
    Zhang HZ; Yu LH; Kim MH
    Platelets; 2013; 24(5):339-47. PubMed ID: 22774770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.